Skip to main content
Figure 1 | BMC Cancer

Figure 1

From: Downregulation of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) in human hepatocellular carcinoma and their prognostic significance

Figure 1

(A) mRNA expression (RT-PCR) of OCT1 ( SLC22A1 ) and OCT3 ( SLC22A3 ) in hepatic tumor cell lines (HepG2, Hep3b, Huh6, Huh7) relative to glyceraldehyde-3-phosphate dehydrogenase (GAPDH). (B) mRNA expression (RT-PCR) of OCT1 (SLC22A1) and OCT3 (SLC22A3) in normal liver tissue of 10 patients relative to GAPDH. (C) Exemplarily mRNA expression (RT-PCR) in eleven patients (1-11) with HCC and the corresponding non neoplastic tumor surrounding tissue (TST). (D) Downregulation of OCT1 (SLC22A1) and OCT3 (SLC22A3) mRNA expression in HCC (n = 53) compared to TST. (E) Individual OCT1 (SLC22A1) and OCT3 (SLC22A3) mRNA expression pattern in each patient (HCC and according TST).

Back to article page
\